These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 38396888)

  • 1. COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?
    Michalak A; Lach T; Szczygieł K; Cichoż-Lach H
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute-on-chronic liver failure by SARS-CoV-2 in active alcohol use disorder cirrhotic patient.
    Testino G; Pellicano R
    Minerva Gastroenterol (Torino); 2021 Sep; 67(3):283-288. PubMed ID: 33971711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.
    Marjot T; Moon AM; Cook JA; Abd-Elsalam S; Aloman C; Armstrong MJ; Pose E; Brenner EJ; Cargill T; Catana MA; Dhanasekaran R; Eshraghian A; García-Juárez I; Gill US; Jones PD; Kennedy J; Marshall A; Matthews C; Mells G; Mercer C; Perumalswami PV; Avitabile E; Qi X; Su F; Ufere NN; Wong YJ; Zheng MH; Barnes E; Barritt AS; Webb GJ
    J Hepatol; 2021 Mar; 74(3):567-577. PubMed ID: 33035628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intersection of Coronavirus Disease 2019 and Alcohol-associated Liver Disease: A Review of Emerging Trends and Implications.
    Aby ES; Vogel AS; Winters AC
    Clin Ther; 2023 Dec; 45(12):1164-1170. PubMed ID: 37758533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management.
    Li P; Liu Y; Cheng Z; Yu X; Li Y
    Biomed Pharmacother; 2022 Oct; 154():113568. PubMed ID: 36029543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease.
    Da BL; Im GY; Schiano TD
    Hepatology; 2020 Sep; 72(3):1102-1108. PubMed ID: 32369624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination.
    Nevola R; Criscuolo L; Beccia D; Delle Femine A; Ruocco R; Imbriani S; Alfano M; Villani A; Russo A; Perillo P; Marfella R; Adinolfi LE; Sasso FC; Marrone A; Rinaldi L
    World J Gastroenterol; 2023 Feb; 29(5):800-814. PubMed ID: 36816617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of COVID-19 on patients with compensated chronic liver diseases.
    Ji D; Zhang D; Yang T; Mu J; Zhao P; Xu J; Li C; Cheng G; Wang Y; Chen Z; Qin E; Lau G
    Hepatol Int; 2020 Sep; 14(5):701-710. PubMed ID: 32734407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: COVID-19 and liver disease-what we know on 1st May 2020.
    Garrido I; Liberal R; Macedo G
    Aliment Pharmacol Ther; 2020 Jul; 52(2):267-275. PubMed ID: 32402090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA).
    Testino G; Vignoli T; Patussi V; Allosio P; Amendola MF; Aricò S; Baselice A; Balbinot P; Campanile V; Fanucchi T; Greco G; Macciò L; Meneguzzi C; Mioni D; Palmieri VO; Parisi M; Renzetti D; Rossin R; Gandin C; Bottaro LC; Bernardi M; Addolorato G; Lungaro L; Zoli G; Scafato E; Caputo F
    Dig Dis Sci; 2022 Jun; 67(6):1975-1986. PubMed ID: 34142284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).
    Sarin SK; Choudhury A; Lau GK; Zheng MH; Ji D; Abd-Elsalam S; Hwang J; Qi X; Cua IH; Suh JI; Park JG; Putcharoen O; Kaewdech A; Piratvisuth T; Treeprasertsuk S; Park S; Wejnaruemarn S; Payawal DA; Baatarkhuu O; Ahn SH; Yeo CD; Alonzo UR; Chinbayar T; Loho IM; Yokosuka O; Jafri W; Tan S; Soo LI; Tanwandee T; Gani R; Anand L; Esmail ES; Khalaf M; Alam S; Lin CY; Chuang WL; Soin AS; Garg HK; Kalista K; Batsukh B; Purnomo HD; Dara VP; Rathi P; Al Mahtab M; Shukla A; Sharma MK; Omata M;
    Hepatol Int; 2020 Sep; 14(5):690-700. PubMed ID: 32623632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes.
    Baldelli L; Marjot T; Barnes E; Barritt AS; Webb GJ; Moon AM
    Gut Liver; 2023 Jan; 17(1):12-23. PubMed ID: 36457261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions-Review of the Literature.
    Bucurica S; Ionita Radu F; Bucurica A; Socol C; Prodan I; Tudor I; Sirbu CA; Plesa FC; Jinga M
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver injury in the era of COVID-19.
    Cichoż-Lach H; Michalak A
    World J Gastroenterol; 2021 Feb; 27(5):377-390. PubMed ID: 33584070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study.
    Ge J; Pletcher MJ; Lai JC;
    Gastroenterology; 2021 Nov; 161(5):1487-1501.e5. PubMed ID: 34284037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver dysfunction and SARS-CoV-2 infection.
    Gracia-Ramos AE; Jaquez-Quintana JO; Contreras-Omaña R; Auron M
    World J Gastroenterol; 2021 Jul; 27(26):3951-3970. PubMed ID: 34326607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020.
    Mallet V; Beeker N; Bouam S; Sogni P; Pol S;
    J Hepatol; 2021 Oct; 75(4):848-855. PubMed ID: 33992699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case-control autopsy series of liver pathology associated with novel coronavirus disease (COVID-19).
    Righi FA; Vander Heide RS; Graham RP; Aubry MC; Trejo-Lopez JA; Bois MC; Roden AC; Reichard R; Maleszewski JJ; Alexander MP; Quinton RA; Jenkins SM; Hartley CP; Hagen CE
    Ann Diagn Pathol; 2024 Feb; 68():152240. PubMed ID: 37995413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease.
    Hartl L; Haslinger K; Angerer M; Semmler G; Schneeweiss-Gleixner M; Jachs M; Simbrunner B; Bauer DJM; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Lampichler K; Halilbasic E; Stättermayer AF; Ba-Ssalamah A; Mandorfer M; Scheiner B; Reiberger T; Trauner M
    Hepatology; 2022 Dec; 76(6):1563-1575. PubMed ID: 35596929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.